ZAZIBONA joint assessment sessions are held quarterly. At these sessions reports for new applications and reports for additional data are jointly assessed. The assessors review the safety, quality and efficacy of medicines intended for marketing, sale and distribution in the SADC countries. To be eligible, a product must have been submitted to a minimum of two countries.

The flow diagram below gives a summary of the dossier review cycle.